Bayer AG
XETRA:BAYN
Bayer AG
Operating Expenses
Bayer AG
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Operating Expenses
-€19.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-2%
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Operating Expenses
-$125.8m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Operating Expenses
-€8.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
MPH Health Care AG
XETRA:93M1
|
Operating Expenses
-€1m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Operating Expenses
-€518.2m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Operating Expenses
-€59m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Operating Expenses?
Operating Expenses
-19.5B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Operating Expenses amounts to -19.5B EUR.
What is Bayer AG's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-2%
Over the last year, the Operating Expenses growth was 15%. The average annual Operating Expenses growth rates for Bayer AG have been 6% over the past three years , 2% over the past five years , and -2% over the past ten years .